Cargando…
Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives
Carcinosarcomas (CS) in gynecology are very infrequent and represent only 2–5% of uterine cancers. Despite surgical cytoreduction and subsequent chemotherapy being the primary treatment for uterine CS, the overall five-year survival rate is 30 ± 9% and recurrence is extremely common (50–80%). Due to...
Autores principales: | Vitale, Salvatore Giovanni, Laganà, Antonio Simone, Capriglione, Stella, Angioli, Roberto, La Rosa, Valentina Lucia, Lopez, Salvatore, Valenti, Gaetano, Sapia, Fabrizio, Sarpietro, Giuseppe, Butticè, Salvatore, Tuscano, Carmelo, Fanale, Daniele, Tropea, Alessandro, Rossetti, Diego |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455008/ https://www.ncbi.nlm.nih.gov/pubmed/28531111 http://dx.doi.org/10.3390/ijms18051100 |
Ejemplares similares
-
The Role of Oxidative Stress and Membrane Transport Systems during Endometriosis: A Fresh Look at a Busy Corner
por: Vitale, Salvatore Giovanni, et al.
Publicado: (2018) -
Hysteroscopic Morcellation of Submucous Myomas: A Systematic Review
por: Vitale, Salvatore Giovanni, et al.
Publicado: (2017) -
Evidence-Based and Patient-Oriented Inositol Treatment in Polycystic Ovary Syndrome: Changing the Perspective of the Disease
por: Laganà, Antonio Simone, et al.
Publicado: (2017) -
Vitamin B12 among Vegetarians: Status, Assessment and Supplementation
por: Rizzo, Gianluca, et al.
Publicado: (2016) -
Anxiety and depression in patients with endometriosis: impact and management challenges
por: Laganà, Antonio Simone, et al.
Publicado: (2017)